Johnson L Robert: insider trades

Director at West Pharmaceutical Services. No open-market purchases and 11 sales not made under a pre-set plan, reported from November 8, 2010 to August 23, 2013.

What happened after Johnson L Robert’s sales?

After their sales, the shares moved +13.9% against the index over 12 months on average (a negative figure means selling was the right call); 36% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Johnson L Robert: trades against the S&P 500 afterwards
Measured	Trades counted	Average vs S&P 500	Median	Went the right way	Years	t-statistic	p-value	Evidence
Purchases, 3 months after the report	0	—	—	—	—	—	—	Not enough years
Purchases, 6 months after the report	0	—	—	—	—	—	—	Not enough years
Purchases, 12 months after the report	0	—	—	—	—	—	—	Not enough years
Purchases, 12 months after the trade	0	—	—	—	—	—	—	Not enough years
Sales, 3 months after the report	11	+6.8%	+11.6%	36%	3	—	—	Not enough years
Sales, 12 months after the report	11	+13.9%	+8.8%	36%	3	—	—	Not enough years
Sales, 12 months after the trade	11	+14.2%	+12.9%	36%	3	—	—	Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

Company	Title on the latest filing	Purchases	Sales	First report	Latest report
West Pharmaceutical Services WST	—	0	11	November 8, 2010	August 23, 2013

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

Reported	Traded	Company	Trade	Value	3 months after report	12 months after report	12 months after trade
August 23, 2013	August 22, 2013	WST	Sale	$144,633	+16.0%	−6.1%	−7.7%
May 28, 2013	May 24, 2013	WST	Sale	$114,699	+14.7%	+8.8%	+12.9%
May 17, 2013	May 17, 2013	WST	Sale	$271,200	+11.6%	+7.8%	+11.1%
May 9, 2013	May 8, 2013	WST	Sale	$412,736	+15.7%	+17.3%	+14.4%
August 21, 2012	August 17, 2012	WST	Sale	$153,920	+12.1%	+43.1%	+39.8%
August 15, 2012	August 14, 2012	WST	Sale	$152,864	+10.6%	+42.9%	+42.5%
May 30, 2012	May 29, 2012	WST	Sale	$110,680	−7.6%	+18.7%	+19.6%
February 29, 2012	February 28, 2012	WST	Sale	$50,596	+18.9%	+32.7%	+34.1%
November 10, 2010	November 8, 2010	WST	Sale	$39,180	−5.4%	−3.6%	−3.3%
November 9, 2010	November 5, 2010	WST	Sale	$78,311	−6.4%	−5.2%	−4.0%
November 8, 2010	November 4, 2010	WST	Sale	$39,130	−5.2%	−3.1%	−3.7%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Johnson L Robert traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.